Paragonix Technologies today announced the first liver transplant case preserving a pediatric donor liver with the Liverguard preservation system.

Dr. Deepak Vikraman successfully transplanted the donor liver at Duke University Hospital in Durham, North Carolina.

“This case exemplifies the importance of employing the latest innovations in transplant preservation within pediatric care,” said Vikraman. “New technologies are pushing the boundaries of what was previously possible. By advancing preservation methods, we can expand donor pools and offer young patients a second chance at life.”

Paraonix launched its Liverguard in 2022 and its use spans more than 300 clinical transplants across the U.S. However, this marks the first case in a pediatric setting.

Liverguard provides a highly controlled, state-of-the-art environment for hypothermic liver preservation. It also features real-time digital monitoring to protect the donor liver throughout the entire transplant process. Unlike traditional methods using ice and off-the-shelf coolers, it marks a significant advancement in transplantation technology.

“We are thrilled to see our technology utilized in the pediatric setting, extending its impact to more liver transplant patients and improving preservation techniques and outcomes for children,” said Dr. Lisa Anderson, CEO and President of Paragonix Technologies. “Partnering with a leading pediatric liver transplant center like Duke University, whose mission it is to provide extraordinary care aligns perfectly with our vision of improving outcomes. It is truly exciting to work together to transform the healthcare system for the better.”